Publications by authors named "Angelo Casa"

Claim this Profile
P
Post-colectomy enteritis with ulcerative colitis: a rare but severe inflammatory condition.
Raffaele Li Voti, Fabio Salvatore Macaluso, Sara Renna, Angelo Casà, Alessandro Termini

Scand J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort study.
Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Clara De Francesco, Nunzio Belluardo

Dig Liver Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.
Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Maria Cappello, Piera Melatti

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.
Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini

Inflamm Bowel Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study.
Fabio Salvatore Macaluso, Elvira D'Antonio, Walter Fries, Anna Viola, Omar Ksissa

Dig Liver Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of ustekinumab in treatment of ulcerative colitis: a narrative review.
Mauro Grova, Alessandro Vitello, Mariella Mannino, Angelo Casà, Sara Renna

Immunotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.
Fabio Salvatore Macaluso, Mauro Grova, Filippo Mocciaro, Roberto Di Mitri, Antonino Carlo Privitera

J Gastroenterol Hepatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics.
Mauro Grova, Federica Crispino, Marcello Maida, Alessandro Vitello, Sara Renna

Dig Liver Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease.
Fabio Salvatore Macaluso, Mauro Grova, Marica Saladino, Maria Cappello, Maria Giulia Demarzo

Dig Liver Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from SB2 to PF-06438179/GP1111 and back in inflammatory bowel disease: "The Superswitchers".
Fabio Salvatore Macaluso, Angelo Casà, Sara Renna, Mauro Grova, Mariella Mannino

Dig Liver Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries, Anna Viola, Alfredo Abbruzzese

Inflamm Bowel Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets.
Federica Crispino, Mauro Grova, Erica Maria Bruno, Noemi Monachino, Giuseppe Rizzo

Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experience.
Mauro Grova, Federica Crispino, Marcello Maida, Sara Renna, Mariella Mannino

Eur J Gastroenterol Hepatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.
Fabio Salvatore Macaluso, Maria Cappello, Federica Crispino, Mauro Grova, Antonino Carlo Privitera

Dig Liver Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.
Fabio Salvatore Macaluso, Maria Cappello, Anita Busacca, Walter Fries, Anna Viola

J Gastroenterol Hepatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based prognostic biomarkers in Crohn's Disease patients on biologics: a promising tool to predict endoscopic outcomes.
Federica Crispino, Mauro Grova, Marcello Maida, Sara Renna, Filippo Mocciaro

Expert Opin Biol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).
Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Giuseppe Costantino, Marco Muscianisi

Expert Opin Biol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: mesalazine-a safe drug with rare serious adverse events.
Barbara Scrivo, Sara Renna, Angelo Casà, Noemi Monachino, Fabio S Macaluso

Aliment Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.
Cemal Erdem, Alison M Nagle, Angelo J Casa, Beate C Litzenburger, Yu-Fen Wang

Mol Cell Proteomics· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor.
Angelo J Casa, Daniel Hochbaum, Sreeja Sreekumar, Steffi Oesterreich, Adrian V Lee

Mol Cell Endocrinol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
Angelo J Casa, Adam S Potter, Simeen Malik, ZaWaunyka Lazard, Isere Kuiatse

Breast Cancer Res Treat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.
Adam S Potter, Angelo J Casa, Adrian V Lee

J Cell Biochem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial.
Cosimo Prantera, Marina Rizzi, Mario Cottone, Angelo Casa, Vito Annese

Dig Liver Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang

Breast Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
Chad J Creighton, Angelo Casa, ZaWaunyka Lazard, Shixia Huang, Anna Tsimelzon

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis